- Home
- UFI vs KOD Comparison
UFI vs KOD Comparison
Compare UFI & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- KOD
- Stock Information
- Founded
- UFI 1969
- KOD 2009
- Country
- UFI United States
- KOD United States
- Employees
- UFI N/A
- KOD 111
- Industry
- UFI Textiles
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UFI Consumer Discretionary
- KOD Health Care
- Exchange
- UFI Nasdaq
- KOD Nasdaq
- Market Cap
- UFI 123.0M
- KOD 149.4M
- IPO Year
- UFI N/A
- KOD 2018
- Fundamental
- Price
- UFI $7.25
- KOD $2.82
- Analyst Decision
- UFI
- KOD Hold
- Analyst Count
- UFI 0
- KOD 5
- Target Price
- UFI N/A
- KOD $3.25
- AVG Volume (30 Days)
- UFI 56.9K
- KOD 158.8K
- Earning Date
- UFI 10-30-2024
- KOD 11-12-2024
- Dividend Yield
- UFI N/A
- KOD N/A
- EPS Growth
- UFI N/A
- KOD N/A
- EPS
- UFI N/A
- KOD N/A
- Revenue
- UFI $582,209,000.00
- KOD N/A
- Revenue This Year
- UFI $16.88
- KOD N/A
- Revenue Next Year
- UFI $3.10
- KOD N/A
- P/E Ratio
- UFI N/A
- KOD N/A
- Revenue Growth
- UFI N/A
- KOD N/A
- 52 Week Low
- UFI $5.41
- KOD $1.37
- 52 Week High
- UFI $7.91
- KOD $7.77
- Technical
- Relative Strength Index (RSI)
- UFI 51.38
- KOD 62.05
- Support Level
- UFI $6.64
- KOD $2.54
- Resistance Level
- UFI $7.04
- KOD $2.75
- Average True Range (ATR)
- UFI 0.28
- KOD 0.13
- MACD
- UFI -0.04
- KOD 0.02
- Stochastic Oscillator
- UFI 47.28
- KOD 100.00
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.